Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $294.40 million. The enterprise value is $310.05 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.74 million shares outstanding. The number of shares has increased by 2.85% in one year.
| Current Share Class | 8.74M |
| Shares Outstanding | 8.74M |
| Shares Change (YoY) | +2.85% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 30.29% |
| Owned by Institutions (%) | 16.42% |
| Float | 3.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.64 |
| Forward PS | 3.04 |
| PB Ratio | 7.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.81.
| Current Ratio | 2.23 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.13 |
Financial Efficiency
Return on equity (ROE) is -20.28% and return on invested capital (ROIC) is -6.54%.
| Return on Equity (ROE) | -20.28% |
| Return on Assets (ROA) | -5.08% |
| Return on Capital (ROIC) | -6.54% |
| Revenue Per Employee | $722,749 |
| Profits Per Employee | -$77,437 |
| Employee Count | 108 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 1.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.42% in the last 52 weeks. The beta is 1.53, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -13.42% |
| 50-Day Moving Average | 34.51 |
| 200-Day Moving Average | 32.48 |
| Relative Strength Index (RSI) | 44.82 |
| Average Volume (20 Days) | 36,359 |
Short Selling Information
The latest short interest is 191,320, so 2.19% of the outstanding shares have been sold short.
| Short Interest | 191,320 |
| Short Previous Month | 207,319 |
| Short % of Shares Out | 2.19% |
| Short % of Float | 5.40% |
| Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $78.06 million and -$8.36 million in losses. Loss per share was -$0.99.
| Revenue | 78.06M |
| Gross Profit | 70.38M |
| Operating Income | -6.66M |
| Pretax Income | -4.89M |
| Net Income | -8.36M |
| EBITDA | -2.25M |
| EBIT | -6.66M |
| Loss Per Share | -$0.99 |
Full Income StatementBalance Sheet
The company has $16.28 million in cash and $31.92 million in debt, giving a net cash position of -$15.65 million or -$1.79 per share.
| Cash & Cash Equivalents | 16.28M |
| Total Debt | 31.92M |
| Net Cash | -15.65M |
| Net Cash Per Share | -$1.79 |
| Equity (Book Value) | 39.45M |
| Book Value Per Share | 4.55 |
| Working Capital | 17.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.80 million and capital expenditures -$187,952, giving a free cash flow of -$1.99 million.
| Operating Cash Flow | -1.80M |
| Capital Expenditures | -187,952 |
| Free Cash Flow | -1.99M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 90.16%, with operating and profit margins of -8.53% and -10.71%.
| Gross Margin | 90.16% |
| Operating Margin | -8.53% |
| Pretax Margin | -10.86% |
| Profit Margin | -10.71% |
| EBITDA Margin | -2.89% |
| EBIT Margin | -8.53% |
| FCF Margin | n/a |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.85% |
| Shareholder Yield | -2.85% |
| Earnings Yield | -2.84% |
| FCF Yield | -0.68% |
Analyst Forecast
The average price target for Sanara MedTech is $44.00, which is 30.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $44.00 |
| Price Target Difference | 30.64% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
Sanara MedTech has an Altman Z-Score of 3.76 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.76 |
| Piotroski F-Score | 4 |